RxDoctor Payments Data
★ My doctorsLook up a doctor →

Quentin Vanmeter

Pediatric Endocrinology · Atlanta, GANPI 1245265453

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $148,265 of the $214,916 with a category attached, or 69.0%. Novo Nordisk accounts for 62.4% of it on its own, with 45 other manufacturers making up the rest. Among pediatric endocrinology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$214,916in general payments, 2019–2025

Across 709 payments — averaging $303.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$134K
  • Sanofi-aventis U.S. LLC$43K
  • Eton Pharmaceuticals, Inc.$13K
  • Tolmar Pharmaceuticals, Inc.$5K
  • Azurity Pharmaceuticals, Inc.$5K
  • AbbVie$2K
  • plus $12K from 40 others
$276,789in research payments, 2019–2025

Across 720 payments — averaging $384.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$107K
  • Eli Lilly$82K
  • AbbVie$60K
  • Pfizer$11K
  • Novo Nordisk Health Care AG$5K
  • Mannkind Corporation$5K
  • plus $6K from 2 others

What the payments were for

  • Consulting fees$21,81910%
  • Speaking & faculty fees$148,26569%
  • Travel & lodging$23,80511%
  • Food & beverage$21,01010%
  • Education$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk181$134,059
Sanofi-aventis U.S. LLC39$42,829
Eton Pharmaceuticals, Inc.6$12,783
Tolmar Pharmaceuticals, Inc.13$5,454
Azurity Pharmaceuticals, Inc.29$5,214
AbbVie70$2,351
Pfizer26$1,662
AstraZeneca11$1,553
Eli Lilly6$1,136
Insulet Corporation45$866
Xeris Pharmaceuticals, Inc.41$721
Ascendis Pharma Endocrinology Inc22$605
BETA Bionics, Inc.10$558
Sequel Med Tech, LLC17$446
Tandem Diabetes Care, Inc.17$414
Medtronic(2 entities)11$374
Endo Pharmaceuticals Inc.21$313
Tolmar, Inc.14$243
Zealand Pharma US, Inc.10$237
Dexcom, Inc.12$226
Ultragenyx Pharmaceutical Inc.6$221
Ipsen Biopharmaceuticals, Inc6$210
IBSA Pharma Inc.8$190
Companion Medical, Inc.4$183
Amneal Pharmaceuticals LLC8$167
Neurocrine Biosciences, Inc.6$158
Ferring Pharmaceuticals Inc.7$153
Kyowa Kirin, Inc.7$153
Bigfoot Biomedical Inc1$152
Lilly USA, LLC9$151
Arbor Pharmaceuticals, Inc.5$127
Amphastar Pharmaceuticals, Inc.6$126
Amryt Pharma Holdings Ltd2$126
Biomarin Pharmaceutical Inc.4$89
Abbott4$75
Kvk-tech, Inc.1$75
Rhythm Pharmaceuticals, Inc.3$71
Mannkind Corporation4$67
Embecta Corp.3$64
Sandoz3$61
Boehringer Ingelheim3$59
Endo USA, Inc.2$52
Soleno Therapeutics, Inc.2$48
Corcept Therapeutics2$42
Amgen1$30
BD1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$214,916 in reported general payments places this provider in the 95th percentile of 30 pediatric endocrinology providers in Georgia.

See all pediatric endocrinology providers in Georgia →

Other pediatric endocrinology in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →